Deaths and cardiovascular events in men receiving testosterone

JAMA

Volumn 311, Issue 9, 2014, Pages 964-

  Dhindsa, Sandeep ^a   Batra, Manav ^b   Dandona, Paresh ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; TESTOSTERONE;

CARDIOVASCULAR DISEASE; DOSE RESPONSE; DRUG DOSE TITRATION; GERIATRIC PATIENT; HORMONAL THERAPY; HORMONE DETERMINATION; HUMAN; LETTER; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; ANDROPAUSE; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; HEART INFARCTION; MALE; NOTE;

ANDROPAUSE; HUMANS; MALE; MYOCARDIAL INFARCTION; STROKE; TESTOSTERONE;

EID: 84895502602     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.389     Document Type: Letter

References (5)

1. Vigen R, O'Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829-1836.
2. Bhasin S, Cunningham GR, Hayes FJ, et al Endocrine Society Task Force. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559.
3. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab. 2008;93(1):68-75.
4. Basaria S, Davda MN, Travison TG, Ulloor J, Singh R, Bhasin S. Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci. 2013;68(2):153-160.
5. Muraleedharan V, Marsh H, Kapoor D, Channer KS, Jones TH. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol. 2013;169(6):725-733.